Literature DB >> 11177572

An alternative-exon database and its statistical analysis.

S Stamm1, J Zhu, K Nakai, P Stoilov, O Stoss, M Q Zhang.   

Abstract

We compiled a comprehensive database of alternative exons from the literature and analyzed them statistically. Most alternative exons are cassette exons and are expressed in more than two tissues. Of all exons whose expression was reported to be specific for a certain tissue, the majority were expressed in the brain. Whereas the length of constitutive exons follows a normal distribution, the distribution of alternative exons is skewed toward smaller ones. Furthermore, alternative-exon splice sites deviate more from the consensus: their 3' splice sites are characterized by a higher purine content in the polypyrimidine stretch, and their 5' splice sites deviate from the consensus sequence mostly at the +4 and +5 positions. Furthermore, for exons expressed in a single tissue, adenosine is more frequently used at the -3 position of the 3' splice site. In addition to the known AC-rich and purine-rich exonic sequence elements, sequence comparison using a Gibbs algorithm identified several motifs in exons surrounded by weak splice sites and in tissue-specific exons. Together, these data indicate a combinatorial effect of weak splice sites, atypical nucleotide usage at certain positions, and functional enhancers as an important contribution to alternative-exon regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11177572     DOI: 10.1089/104454900750058107

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  69 in total

1.  ASD: the Alternative Splicing Database.

Authors:  T A Thanaraj; Stefan Stamm; Francis Clark; Jean-Jack Riethoven; Vincent Le Texier; Juha Muilu
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome.

Authors:  Mihaela Zavolan; Shinji Kondo; Christian Schonbach; Jun Adachi; David A Hume; Yoshihide Hayashizaki; Terry Gaasterland
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

3.  Large scale study of protein domain distribution in the context of alternative splicing.

Authors:  Shuo Liu; Russ B Altman
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

4.  Genome-wide detection of tissue-specific alternative splicing in the human transcriptome.

Authors:  Qiang Xu; Barmak Modrek; Christopher Lee
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

5.  Splice variation in mouse full-length cDNAs identified by mapping to the mouse genome.

Authors:  Mihaela Zavolan; Erik van Nimwegen; Terry Gaasterland
Journal:  Genome Res       Date:  2002-09       Impact factor: 9.043

6.  Detection and evaluation of intron retention events in the human transcriptome.

Authors:  Pedro Alexandre Favoretto Galante; Noboru Jo Sakabe; Natanja Kirschbaum-Slager; Sandro José de Souza
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

7.  Prolyl 4-hydroxylase genes are subjected to alternative splicing in roots of maize seedlings under waterlogging.

Authors:  Xiling Zou; Yuanyuan Jiang; Yonglian Zheng; Meidong Zhang; Zuxin Zhang
Journal:  Ann Bot       Date:  2011-10-03       Impact factor: 4.357

8.  Alternative splicing of the Drosophila Dscam pre-mRNA is both temporally and spatially regulated.

Authors:  A M Celotto; B R Graveley
Journal:  Genetics       Date:  2001-10       Impact factor: 4.562

9.  Conservation of human alternative splice events in mouse.

Authors:  T A Thanaraj; Francis Clark; Juha Muilu
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

10.  Inferring alternative splicing patterns in mouse from a full-length cDNA library and microarray data.

Authors:  Hiromi Kochiwa; Ryosuke Suzuki; Takanori Washio; Rintaro Saito; Hidemasa Bono; Piero Carninci; Yasushi Okazaki; Rika Miki; Yoshihide Hayashizaki; Masaru Tomita
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.